Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

NCT07085039 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
14
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Pennsylvania

Collaborators